Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lorena Mosso G is active.

Publication


Featured researches published by Lorena Mosso G.


Revista Medica De Chile | 2000

Exceso de mineralocorticoides en hipertensos esenciales: enfoque clínico-diagnóstico

Paola Cortés P; Carlos Fardella B; Eveline Oestreicher C.; Homero Gac E; Lorena Mosso G; Julia Soto M.; Arnaldo Foradori C; Ximena Claverie R; Jessica Ahuad N; Joaquín Montero L

Background: Primary hyperaldosteronism is more frequent among subjects with essential hypertension than previously thought. The prevalence, according to local and international evidence could fluctuate between 9 and 10%. Aim: To investigate if subjects with essential hypertension have different aldosterone and renin plasma levels than normotensive subjects. Patients and methods: One hundred twenty five subjects with essential hypertension, not receiving medications for at least two weeks prior to the study and 168 age and sex matched normotensive controls were studied. Blood was drawn between 9 and 10 AM during a sodium free diet to determine plasma aldosterone, plasma renin activity and potassium. Results: Plasma aldosterone was higher in hypertensive subjects than controls (11.6 ± 7.6 and 9.9 ± 5.1 ng/dl respectively; p=0.04). Plasma renin activity was lower in hypertensives than controls (1.42 ± 1.28 and 1.88 ± 1.39 ng/ml/h respectively; p<0.001). Thus, plasma aldosterone/plasma renin activity ratio was higher in hypertensives (13.8 ± 13.5 and 8.3 ± 7.8; p<0.001). A pathological ratio was defined as over 25, corresponding to the mean plus two standard deviations of the control group. Primary hyperaldosteronism was found in 5/125 hypertensives (4%) and 1/168 normotensive subject (0.6%). None had hypokalemia. Conclusions: Subjects with essential hypertension have higher plasma aldosterone and lower plasma renin activity than normal controls. A plasma aldosterone/plasma renin activity over 25 was defined as abnormal. (Rev Med Chile 2000; 128: 955-61)


Revista Medica De Chile | 2005

Características de presentación del microcarcinoma papilar del tiroides: Experiencia retrospectiva de los últimos 12 años

Carlos Fardella B; Marcela Jiménez M; Hernán González D; Augusto León R; Ignacio Goñi E.; Francisco Cruz O.; Antonieta Solar G; Javiera Torres M; Lorena Mosso G; Gilberto González; José Adolfo Rodríguez P.; Claudia Campusano M.; José M López M.; Eugenio Arteaga U.

BACKGROUND Thyroid microcarcinoma is a tumor of 10 mm or less, that should have a low risk of mortality. However, a subgroup of these carcinomas is as aggressive as bigger tumors. AIM To describe the pathological presentation of these tumors, and compare them with larger tumors. MATERIAL AND METHODS All pathological samples of thyroid carcinoma that were obtained between 1992 and 2003, were studied. In all biopsies, the pathological type, tumor size, the focal or multifocal character, the presence of lymph node involvement and the presence of lymphocytic thyroiditis or thyroid hyperplasia, were recorded. RESULTS One hundred eighteen microcarcinomas and 284 larger tumors were studied. The mean age of patients with microcarcinoma and larger tumors was 42.7+/-14 and 49.3+/-16 years respectively (p <0,001) and 83% were female, without gender differences between tumor types. Mean size of microcarcinomas was 8.6 mm and 116 (98%) were papillary carcinomas. Of these, 109 (94%) were well differentiated and seven (6%) were moderately differentiated. Thirty six (31%) were multifocal and in 10 (8,6%), there was lymph node involvement. The mean size of larger tumors was 23.8 mm and 241 (85%) were papillary carcinomas. Of these, 200 (83%) were well differentiated, and 41 (17%) were moderately differentiated. Eighty five (35%) were multifocal and in 44 (18%) there was lymph node involvement. The prevalence of thyroiditis and hyperplasia was significantly higher among microcarcinomas than in larger tumors (15 and 2.5%, respectively, p <0.001, for the former; 32.4 and 1.7%, respectively, p <0.001, for the latter). CONCLUSIONS In this series, one third of microcarcinomas were multifocal and 10% had lymph node involvement. Therefore, the aggressiveness of these tumors is higher than what is reported in the literature and they should be treated with total thyroidectomy.


Revista Medica De Chile | 2000

Recambio óseo en nodrizas adolescentes: evaluación al término de la gestación, lactancia y postdestete

Andreina Cattani O; Tamara Zubarew G; Matilde Maddaleno H.; Lorena Mosso G; José M López M.

BACKGROUND There is paucity of information about bone metabolism during pregnancy or breast feeding in teenagers. AIM To study bone turnover at the end of pregnancy and during breast feeding in teenagers and correlate it with environmental, hormonal or nutritional variables. SUBJECTS AND METHODS Thirty teenagers during their breast feeding period after a first pregnancy and 30 nulliparous girls matched for age, age of menarche and body mass index were assessed three weeks after delivery (period 1), at six months of breast feeding (period 2) and one year after the lactating period (period 3). Calcium intake and plasma calcium, phosphorus, alkaline phosphatases, parathormone, estradiol and prolactin were measured. Calcium, creatinine and hydroxyproline were also measured in a morning urine sample. RESULTS Lactating and control girls were aged 16.3 +/- 0.8 and 16.1 +/- 0.7 years old respectively. Calcium intake in lactating and control girls was 798 +/- 421 and 640 +/- 346 g/day respectively in period 1, 612 +/- 352 and 592 +/- 309 mg/day in period 2 and 495 +/- 180 and 456 +/- 157 g/day in period 3. During periods 1 and 2, lactating girls had higher alkaline phosphatases (161 +/- 37 compared to 119 +/- 28 U/l and 149 +/- 37 compared to 106 +/- 23 U/l), parathormone (4.3 +/- 2.6 compared to 2.8 +/- 0.8 ng/dl and 3.6 +/- 1.6 compared to 3.0 +/- 0.9 ng/dl) and urinary hydroxyproline (95 +/- 16 compared to 63 +/- 15 mg/g creatinine and 84 +/- 19 compared to 59 +/- 15 mg/g creatinine). No differences were observed in period 3. No correlation between bone turnover variables, body mass index or hormonal parameters, was observed. CONCLUSIONS In teenagers, there is an increase in bone turnover at the end of pregnancy, that persists during the lactating period. These changes are not related to nutritional or hormonal variables.


Revista Medica De Chile | 2007

Tiroglobulina y sus limitaciones en el seguimiento del carcinoma diferenciado del tiroides: Report of two cases

Soledad Velasco L; Antonieta Solar G; Francisco Cruz O.; Juan Carlos Quintana F; Augusto León R; Lorena Mosso G; Carlos E. Fardella

Thyroid carcinoma is the most prevalent endocrine tumor, and the papillary carcinoma (PC) is the most common histological type. In the follow-up, after thyroidectomy serum thyroglobulin (s-Tg) is used as a marker to evaluate recurrence of thyroid carcinoma. In most cases, this parameter allows an adequate diagnosis, but occasionally s-Tg may miss the detection of a recurrence. We report a 57 year-old female and a 36 year-old male subjected to a total thyroidectomy for a papillary thyroid carcinoma with intermediate and high-risk of recurrence. Both had a cervical recurrence without a concomitant increase in s-Tg levels. In both, Tg staining was positive in the tumor cells. These cases confirm that in these patients, the follow-up must be done with measurement of s-Tg and complementary diagnostic tests.Thyroid carcinoma is the most prevalent endocrine tumor, and the papillary carcinoma (PC) is the most common histological type. In the follow-up, after thyroidectomy serum thyroglobulin (s-Tg) is used as a marker to evaluate recurrence of thyroid carcinoma. In most cases, this parameter allows an adequate diagnosis, but occasionally s-Tg may miss the detection of a recurrence. We report a 57 year-old female and a 36 year-old male sujected to a total thyroidectomy for a papillary thyroid carcinoma with intermediate and high-risk of recurrence. Both had a cervical recurrence without a concomitant increase in s-Tg levels. In both, Tg staining was positive in the tumor cells. These cases confirm that in these patients, the follow-up must be done with measurement of s-Tg and complementary diagnostic tests


Revista Medica De Chile | 2005

Microcarcinoma tiroideo de evolución agresiva: Report of one case

Lorena Mosso G; Marcela Jiménez M; Hernán González D; Antonieta Solar G; Javiera Torres M; Carlos Fardella B

The treatment of papillary thyroid carcinoma of less than 10 mm diameter is a matter of controversy. The incidental finding of papillary microcarcinomas in autopsies is frequent and some authors postulate that these tumors are biologically inactive and should only be observed. We report a 21 years old woman with a papillary thyroid cancer of 6x5x5 mm and bilateral paratracheal metastases, that was subjected to a total thyroidectomy. She received 200 mCi of radioiodine. Two years after surgery, a new nodule of 9.6 mm diameter was detected by ultrasound, that was treated with a new dose of 200 mCi of radioiodine. One year later a suprasternal mass of 2 cm diameter and 3 enlarged lymph nodes were detected. She was subjected to a surgical lymph node dissection of the neck and the biopsy confirmed the presence of cancer. She received a new dose of 300 mCi of radioiodine. The mother of the patient had a 7 mm thyroid nodule that was also a papillary carcinoma (Rev Med Chile 2005; 133: 323-6)The treatment of papillary thyroid carcinoma of less than 10 mm diameter is a matter of controversy. The incidental finding of papillary microcarcinomas in autopsies is frequent and some authors postulate that these tumors are biologically inactive and should only be observed. We report a 21 years old woman with a papillary thyroid cancer of 6 x 5 x 5 mm and bilateral paratracheal metastases, that was subjected to a total thyroidectomy. She received 200 mCi of radioiodine. Two years after surgery, a new nodule of 9.6 mm diameter was detected by ultrasound, that was treated with a new dose of 200 mCi of radioiodine. One year later a suprasternal mass of 2 cm diameter and 3 enlarged lymph nodes were detected. She was subjected to a surgical lymph node dissection of the neck and the biopsy confirmed the presence of cancer. She received a new dose of 300 mCi of radioiodine. The mother of the patient had a 7 mm thyroid nodule that was also a papillary carcinoma.


Revista Medica De Chile | 2001

Isquemia miocárdica reversible en el hipotiroidismo: comunicación de un caso

Iván Quevedo L; Lorena Mosso G; José Miguel Domínguez R-T.; Alejandro Fajuri N.; Juan Carlos Quintana F

A silent, reversible myocardial ischemia with normal coronary angiography and reversible with thyroid hormone substitution, has been recently described in hypothyroid patients. We report a 49 years old male with an abnormal exercise electrocardiogram detected in a preventive medical examination. He had laboratory evidence of hypothyroidism and a history of two years of asthenia and progressive coarsening of the voice. The Thallium myocardial perfusion study, showed an alteration of coronary flow during exercise in the septum and lower wall of the left ventricle. Thyroid hormone substitution was started and three months later, a coronary angiography was normal. After six months a repeated Thallium perfusion study and exercise electrocardiogram were informed as normal (Rev Med Chile 2001; 129: 1320-4)


Revista Medica De Chile | 2002

Actividad de 11 beta hidroxiesteroide dehidrogenasa tipo 2 en hipertensos chilenos

Lorena Mosso G; Cristian Carvajal M; Carmen CampinoJ; Auristela Rojas O.; Alexis González P; Adolfo Barraza M; Joaquín Montero L; Carlos Fardella B

Background: Half of hypertensive patients with low plasma renin activity have a primary hyperaldosteronism. Among the remaining half, 11s-hydroxysteroid dehydrogenase type 2 (11sHSD2) deficiency plays an important role. This enzyme catalyzes the conversion of cortisol to cortisone, avoiding the interaction of cortisol with the mineralocorticoid receptor. If the enzyme fails, cortisol will stimulate sodium and water reabsorption and increase blood pressure. Aim: To determine biochemical alterations, suggestive of 11sHSD2 deficiency, in low-renin hypertensive patients. Patients and Methods: Twenty eight hypertensive patients with a plasma renin activity of less than 0.5 ng/ml/h and with a plasma aldosterone of less than 5 ng/dl were studied. Twenty eight normotensive patients were studied as controls. Serum cortisol (RIA), cortisone (ELISA) and the serum cortisol/cortisone ratio were determined in all of them, between 9 and 10 AM. Measurements were confirmed by high pressure liquid chromatography. The serum cortisol/cortisone ratio was considered abnormal when its Ln (cortisol/cortisone) value was over 2 standard deviations of the mean. Results: Serum cortisol was higher in hypertensive subjects than in controls (11.1±3.3 and 9.2±2.8 µg/dl, respectively; p <0.05). No differences were observed in serum cortisone (3.4±1.3 and 3.7±1.2 µg/dl, respectively). Four hypertensive subjects had an abnormally high Ln (cortisol/cortisone) value (1.86; 1.73; 2.07 and 2.01, considering a normal value of less than 1.61). Conclusions: Four of 28 hypertensive subjects with low plasma renin activity and aldosterone had biochemical alterations suggestive of 11sHSD2 deficiency (Rev Med Chile 2002; 130: 1201-8).


Revista Medica De Chile | 1999

Alta prevalencia de hiperaldosteronismo primario no diagnosticado en hipertensos catalogados como esenciales

Lorena Mosso G; Carlos Fardella Bello; Joaquín Montero Labbé; Verónica Rojas V.; Auristela Rojas O.; Alvaro Huete G; Julia Soto M.; Arnaldo Foradori Curtarelli


Archive | 2005

Microcarcinoma tiroideo de evolución agresiva

Lorena Mosso G; Marcela Jiménez M; Hernán González D; Antonieta Solar G; Javiera Torres M; Carlos E. Fardella


Revista Medica De Chile | 1999

Hipertiroxinemia con eutiroidismo clínico: análisis a propósito de un caso

José Manuel López Moreno; Lorena Mosso G; Carmen Campino J.

Collaboration


Dive into the Lorena Mosso G's collaboration.

Top Co-Authors

Avatar

Antonieta Solar G

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Carlos Fardella B

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Augusto León R

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Carlos E. Fardella

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Francisco Cruz O.

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Hernán González D

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Javiera Torres M

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

José M López M.

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Juan Carlos Quintana F

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Marcela Jiménez M

Pontifical Catholic University of Chile

View shared research outputs
Researchain Logo
Decentralizing Knowledge